Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient.

We report a case of non-Hodgkin's lymphoma (NHL) successfully treated with combination chemotherapy during pregnancy. The histological diagnosis was large-cell B-type NHL. Four courses of chemotherapy with epirubicin, vincristine and prednisolone were given before delivery. The patient is in complete remission and her baby, now four years old, has developed normally. To our knowledge, this is the first reported case of epirubicin administration during pregnancy and in which chemotherapy was given safely to NHL patients during the second and third trimester of pregnancy.

[1]  L. Gordon,et al.  Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.

[2]  R. Weiss,et al.  Lymphoma and pregnancy. , 1989, Seminars in oncology.

[3]  Q. S. Ringenberg,et al.  Antineoplastic agents and pregnancy. , 1989, Seminars in oncology.

[4]  K. Costeloe,et al.  Transplacental effects of maternal cancer chemotherapy. Case report , 1989, British journal of obstetrics and gynaecology.

[5]  E. Papiernik,et al.  Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester , 1989, Prenatal diagnosis.

[6]  B. Coiffier,et al.  LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Turchi,et al.  Anthracyclines in the treatment of malignancy in pregnancy , 1988, Cancer.

[8]  S M Hubbard,et al.  The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture. , 1987, Cancer research.

[9]  J. Mulvihill,et al.  Pregnancy outcome in cancer patients. Experience in a large cooperative group , 1987 .

[10]  W. Travis,et al.  A Report of Three Cases , 1986 .

[11]  R. J. Cersosimo,et al.  Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Polliack,et al.  Non‐Hodgkin's lymphoma associated with pregnancy a report of six cases, with a review of the literature , 1985, Cancer.

[13]  A. Garg,et al.  Non-Hodgkin's lymphoma in pregnancy. , 1985, Southern medical journal.

[14]  A. Kauppila,et al.  Cell-mediated Immunocompetence of Children Exposed in Utero to Short- or Long-term Action of Glucocorticoids , 1983 .

[15]  J. Mulvihill,et al.  Pregnancy outcome following cancer chemotherapy. , 1980, The American journal of medicine.

[16]  I. Simson,et al.  Non‐Hodgkin's lymphoma in pregnancy , 1980, Cancer.

[17]  J. Ortega.  Multiple agent chemotherapy including bleomycin of non‐hodgkin's lymphoma during pregnancy , 1977, Cancer.

[18]  J. Armitage,et al.  Burkitt lymphoma during pregnancy with bilateral breast involvement. , 1977, JAMA.

[19]  W. Gibbs,et al.  Hodgkin's disease in pregnancy: a report of three cases. , 1976, The West Indian medical journal.

[20]  P. Armon.  BURKITT'S LYMPHOMA OF THE OVARY IN ASSOCIATION WITH PREGNANCY TWO CASE REPORTS , 1976, British journal of obstetrics and gynaecology.

[21]  M. J. Garrett.  Letter: Teratogenic effects of combination chemotherapy. , 1974, Annals of internal medicine.

[22]  C. Cohen,et al.  Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. , 1973, American journal of obstetrics and gynecology.

[23]  J. Miller,et al.  Multiple late complications of therapy with cyclophosphamide, including ovarian destruction. , 1971, The American journal of medicine.

[24]  J. Potter,et al.  Metastasis of maternal cancer to the placenta and fetus , 1970, Cancer.

[25]  R. Siegel,et al.  Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .

[26]  H. Nicholson.  CYTOTOXIC DRUGS IN PREGNANCY , 1968 .

[27]  H. L. Riva,et al.  Pregnancy and Hodgkin’s Disease , 1953 .

[28]  Edwin Silverberg,et al.  Cancer statistics, 1989 , 1989 .

[29]  L. Weinstein,et al.  The effects of cancer chemotherapeutic agents on the developing fetus. , 1983, Obstetrical & gynecological survey.

[30]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[31]  Humphrey Dc,et al.  Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy. , 1982 .

[32]  M. Weil,et al.  [Fetal risk of cancer chemotherapy (author's transl)]. , 1979, Bulletin du cancer.

[33]  Kouichi R. Tanaka,et al.  Acute leukemia in pregnancy: transient neonatal myelosuppression after combination chemotherapy in the mother. , 1979, Medical and pediatric oncology.

[34]  R. Levine,et al.  Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents. , 1971, American journal of obstetrics and gynecology.